07:00 , May 14, 2001 |  BioCentury  |  Finance

Ebb & Flow

While recent buyers of Rosetta (RSTA) stock may be dancing in the tulips over the big premium Merck (MRK) is paying to acquire the bioinformatics company, investors who bought the issue either on the August...
07:00 , May 14, 2001 |  BioCentury  |  Finance

Ebb & Flow

While recent buyers of Rosetta (RSTA) stock may be dancing in the tulips over the big premium Merck (MRK) is paying to acquire the bioinformatics company, investors who bought the issue either on the August...
07:00 , Oct 11, 1999 |  BC Week In Review  |  Company News

Bio-Discovery, ZymoGenetics deal

ZymoGenetics, a wholly-owned subsidiary of Novo Nordisk A/S (Bagsvaerd, Denmark), will have a one year exclusive option period to evaluate Bio-Discovery's B-D001 complement inhibitor, which is in preclinical development to prevent reperfusion injury in myocardial...